Concepedia

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Tomáš Kalinčík, J William L Brown, Neil P. Robertson, Mark Willis, Neil Scolding, Claire M Rice, Alastair Wilkins, Owen Pearson, Tjalf Ziemssen, Michael Hutchinson,

The Lancet Neurology · 2017 · 162 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text

, , +10

Cox's Regression Model for Counting Processes: A Large Sample Study

P. Andersen, Richard D. Gill · The Annals of Statistics · 1982 · 4.4K citations

, , +16

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

, , +14

Reducing Bias in Observational Studies Using Subclassification on the Propensity Score

Paul R. Rosenbaum, Donald B. Rubin · Journal of the American Statistical Association · 1984 · 3.2K citations · Full text

, , +17

Reducing Bias in Observational Studies Using Subclassification on the Propensity Score

Paul R. Rosenbaum, Donald B. Rubin · Journal of the American Statistical Association · 1984 · 3.1K citations

, , +17